Buy or sell Tempus stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Tempus Stock

Tempus is a technology company that has built an operating system to battle cancer.

Founded

2015

Notable Investors

Headquarters

Chicago IL, US

Total Funding

$320M

About Tempus Stock

Tempus is a technology company that has built an operating system to battle cancer. It is on a mission to redefine how genomic data is used in a clinical setting. Their goal is for each patient to benefit from the treatment of others who came before by enabling physicians to deliver personalized cancer care for patients through interactive analytical and machine learning platform.

Funding History

September 2015$10.0M
June 2016$10.0M
November 2016$10.0M
April 2017$30.0M
September 2017$70.0M
March 2018$80.0M
August 2018$110M

Management

Executive Vice President and General Counsel

Erik Phelps

Chief Operating Officer

Ryan Fukushima

President

Kevin White

Co-founder and CEO

Eric Lefkofsky

CTO

Shane Colley

Head of Strategic Partnerships

Sasha Gribov

Director of Pathology and Medical Lab Operations

Nike Beaubier

Chief Medical Officer

Gary Palmer

Press

Other Companies

Logo
AlphaSense

AlphaSense is a smart Financial Search Engine that provides sophisticated semantic analytics to give you an unprecedented information edge

Logo
Auris Health, Inc.

Robotic endoscopy medical device company

Logo
CrossChx

Provides healthcare identity management solutions

Logo
Lemonade

insurance company powered by AI and behavioral economics

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Tempus or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo

Logo